R&D Costs, Rx Prices, and the Formula for Success in Life Sciences Innovation, With Stephen Ezell
Innovation Files: Where Tech Meets Public Policy
Prescription Drug Prices - Are They Too High?
Drug prices over the past two decades have not risen in total in any way out of line with either the overall increase in health care, in medical system cost. Drug companies depend upon profits from one generation of innovation to finance investment in the next. If we severely constrict the ability of these companies to earn revenues, we are going to have both less innovation in the future and less availability to those drugs.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
